Larig
TYPE: Prescription

BRAND: Larig

ACTIVE INGREDIENT: Lamotrigine

STRENGTH & PACK SIZE & GMS CODES:
25 mg Dispersible Tablets x 56 ~ 30622
50 mg Dispersible Tablets x 56 ~ 30641
100 mg Dispersible Tablets x 56 ~ 30664
200 mg Dispersible Tablets x 56 ~ 30692


INDICATION:

Epilepsy

Adults:
Lamotrigine is indicated for use as adjunctive or monotherapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut Syndrome.

Children:
Lamotrigine is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with Lennox-Gastaut Syndrome.

Initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

After epileptic control has been achieved during adjunctive therapy, concomitant anti-epileptic drugs (AEDs) may be withdrawn and patients continued on Lamotrigine monotherapy.

Bipolar Disorder (Adults 18 Years of Age and Over):
Lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder, predominantly by preventing depressive episodes.

 

 

Download Larig 25mg SPC here

Download Larig 50mg SPC here

Download Larig 100mg SPC here

Download Larig 200mg SPC here

Download Larig 25mg, 50mg, 100mg & 200mg PIL here




Back to Prescription Products page
Sitemap